Hoth Therapeutics to Attend Sequire Investor Summit January 21-23, 2025

Company Overview - Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative treatments aimed at improving patient quality of life [2] - The company engages in early-stage pharmaceutical research and development, advancing drugs from bench to pre-clinical and clinical testing [2] - Hoth Therapeutics employs a patient-centric approach, collaborating with scientists, clinicians, and key opinion leaders to explore therapeutics with significant potential [2] Recent Developments - Robb Knie, the CEO of Hoth Therapeutics, is scheduled to attend the Sequire Investor Summit, indicating the company's engagement with investors and the broader financial community [1]